Vaccination: A new option to reduce the burden of herpes zoster

Expert Review of Vaccines

Volumn 9, Issue SUPPL. 3, 2010, Pages 31-35

  Mick, Gérard ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

Herpes zoster; Herpes zoster vaccine; Postherpetic neuralgia; Quality of life

Indexed keywords

VARICELLA ZOSTER VACCINE;

AGED; CLINICAL TRIAL; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG INDUCED HEADACHE; HERPES ZOSTER; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE RASH; INJECTION SITE SWELLING; PRIORITY JOURNAL; REVIEW; VACCINATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; DRUG TOXICITY; HEADACHE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; INCIDENCE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN DISEASES; TIME FACTORS; VACCINES, ATTENUATED;

EID: 77649315126     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.32     Document Type: Review

References (17)

1. Yawn BP, Saddier P, Wallen PC et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin. Proc. 82, 1341-1349 (2007).
2. Brisson M, Edmunds WJ, Law B et al. Epidemiology of varicella-zoster virus infection in Canada and the United Kingdom. Epidemiol. Infect. 127, 305-314 (2001).
3. Lydick. E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 45 (Suppl. 8), S52-S53 (1995).
4. Schmader KE, Sloane R, Pieper C et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin. J. Pain 23, 490-496 (2007).
5. Schmader K. Herpes zoster in older adults. Clin. Infect. Dis. 32, 1481-1486 (2001).
6. Oster G, Harding G, Dukes E et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J. Pain 6, 356-363 (2005).
7. Hempenstall K, Nurmikko TJ, Johnson RW et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2, E164 (2005).
8. Burke BL, Steele RW, Beard OW et al. Immune responses to varicella-zoster in the aged. Arch. Intern. Med. 142, 291-293 (1982).
9. Arvin A. Aging, immunity and the varicella-zoster virus. N. Engl. J. Med. 352, 2266-2267 (2005).
10. Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older patients. N. Engl. J. Med. 352, 2271-2284 (2005).
11. Oxman MN. Vaccination to prevent herpes zoster and postherpetic neuralgia. Hum. Vaccin. 3, 64-68 (2007).
12. Schmader K, Oxman M, Levin M et al. Persistence of zoster vaccine efficacy. Presented at: 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual meeting of the Infectious Diseases Society of America (IDSA). Washington DC, USA, Abstract G-409, 25-28 October 2008.
13. Kerzner B, Murray AV, Cheng E et al. Safety and immunogenicity profile of concomitant administration of Zostavax and inactivated influenza vaccine in adult aged 50 and older. J. Am. Geriatr. Soc. 55, 1499-1507 (2007).
14. Manintyre R, Egerton T, McCaughey M et al. Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old. Presented at: 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual meeting of the Infectious Diseases Society of America (IDSA). Washington DC, USA, Abstract G-399d, 25-28 October 2008.
15. Summary of Product Characteristics Zostavax, Sanofi Pasteur MSD (2009).
16. Mills R, Tyring SK, Lawless JF et al. Safety, tolerability and immunogenicity of zoster vaccine in subjects with a history of herpes zoster. Presented at: 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual meeting of the Infectious Diseases Society of America (IDSA). Washington DC, USA, Abstract G-407, 25-28 October 2008.
17. Cunningham AL, Breuer J, Dwyer DE et al. The prevention and management of herpes zoster. Med. J. Aust. 188, 171-176 (2008).